ADHD is a childhood disorder. It is a cognitive and neurobehavioral condition in the brain that requires comprehensive medical treatment for many people. According to the FDA, Medical stimulants are the effective treatment for Pediatric ADHD and other sleep disorders. Quillivant XR is a prescription medical stimulant that is approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children over 6 years of age and adults. It also has an extended-release liquid formulation, which offers control of symptoms for up to 12 hours.
Find out how Quillivant XR can treat ADHD with benefits and effectiveness.
Quillivant XR
Quillivant XR is a central nervous stimulant containing the active ingredient Methylphenidate. It is available in the extended banana-flavoured liquid formulation called Methylphenidate ER Liquid. Quillivant is not a generic medication but offers flexible dosing for children. According to the American Academy of Pediatrics, Quillivant XR is an effective ADHD treatment for children above 6 years old due to its symptom control span.
How does Quillivant XR work to manage Pediatric ADHD Symptoms?
As a central nervous stimulant, Quillivant XR regulates two neurotransmitters (Dopamine and Norepinephrine) in the area of the brain that manages ADHD symptoms in children. It improves concentration, impulse control, daytime oversleep issues, attention, and overall cognitive functioning. The National Institute for Health and Care Excellence (NICE) recommends methylphenidate ER Liquid for children ages six and older. They also mentioned Quillivant XR as a first-line treatment option for children who have ADHD. The Quillivant XR extended-release liquid formulation contains 12 hours of control over ADHD symptoms.
Benefits of Quillivant XR Liquid for Pediatric ADHD Management
Quillivant XR is the first liquid stimulant that offers several benefits, including personalized dosing for children. Its liquid formulation is more convenient for children who struggle to swallow pills. It helps children improve their pronounced difficulties in social interactions and interpersonal relationships. Quillivant also reduces restlessness, impulsivity, and side effects.
How long does Quillivant XR last in the body?
Quillivant XR is a long-lasting medical stimulant that works as a symptom reliever. The effects begin to appear at 25 minutes and peak at 5 to 6 hours later. After that, it lasts up to 12 hours and then slowly wears off from the body. Since extended liquid formulations are convenient for children, they can take the medication once daily, which provides continual control of their symptoms. Recent research found that the significant improvement of Quillivant XR is in between 1 to 2 weeks.
Quillivant XR Side Effects: A Parent’s Guide
Parents must know about side effects before starting Quillivant XR as medicine. Quillivant XR is a tolerated stimulant, but it has some common side effects, including:
- Nausea and Vomiting
- Indigestion
- Weightloss
- Skin Rash
- Tics
- Headache
- Eye Pain
Quillivant also has some serious side effects, but it is rare in children, including:
- High Heartbeat
- Seizures
- Behavioural changes (Mania)
- Slowed Growth Rate
Overall, these side effects have an appealing risk during the first year of treatment without considering active symptoms. It is important to consult with a healthcare professional to determine the right dosage for the child.
Quillivant XR for Children: How can dosage be adjusted for maximum effectiveness?
The banana-flavoured Liquid ER Methylphenidate dosage for children varies by their metabolism. It doesn’t depend on age, weight, or height. As a medical stimulant, Quillivant XR’s initial dosage starts from 5 to 10mg once daily. After that, it can be adjusted according to the patient’s needs. Quillivant is recommended for use in the treatment of ADHD at a dose of 60 mg per day. This liquid ADHD medication should be taken once in the morning.
Additionally, during treatment, your healthcare provider can monitor your symptoms and adjust the dose, which can lead to mild indigestion. As Quillivant is a controlled substance, don’t follow others’ dosage plans. Parents need to consult with healthcare providers while taking Quillivant XR to determine the accurate dosage guidance.
Choosing the right ADHD Pediatric Medication: Is Quillivant XR right for your children?
As a parent, it is crucial to choose the right and safe medication for a child. Quillivant is considered safe for children over 6 years and older. This liquid ADHD medication is more convenient for children to take without swallowing or chewing. Due to its long-acting formulation, it is the best alternative to Ritalin and Concerta. Quillivant XR provides flexible dosing and long-lasting symptom relief that helps a child stay active and focused. Before starting medication, parents should consult with healthcare professionals.
Conclusion
Quillivant XR (Methylphenidate ER Liquid) is a liquid formulation medication that plays a crucial role in the treatment of pediatric ADHD. It is safe and effective for children who struggle with hard pills. Quilliavnt is primarily increasing in the ADHD treatment due to its 12-hour symptom control. While starting this liquid ADHD medication, it is significant to consider its side effects and benefits.
Reference list
Aungst, C. (2013). Quillivant XR: A Once Daily Liquid ADHD Treatment. [online] GoodRx. Available at: https://www.goodrx.com/quillivant-xr/a-once-daily-liquid-adhd-treatment-quillivant-xr [Accessed 3 Nov. 2024].
Greenhill, L.L., Swanson, J.M., Hechtman, L., Waxmonsky, J., Arnold, L.E., Molina, B.S.G., Hinshaw, S.P., Jensen, P.S., Abikoff, H.B., Wigal, T., Stehli, A., Howard, A., Hermanussen, M. and Hanć, T. (2020). Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 59(8), pp.978–989. doi:https://doi.org/10.1016/j.jaac.2019.06.019.
Pheils, J. and Ehret, M.J. (2021). Update on methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder. American Journal of Health-System Pharmacy, 78(10), pp.840–849. doi:https://doi.org/10.1093/ajhp/zxab069.
